Prime Minister Vladimir Putin on Friday called for boosting the share of medicine produced by local companies to at least 50 percent of total sales within three years, from 20 percent now.
“Overseas drugs are often sold in Russia at prices that are several times higher than in other countries,” Putin said at a meeting on the pharmaceuticals industry in Zelenograd.
He said the difference was impossible to explain, since transportation costs were no more than 0.2 percent of total costs. About 350 Russian companies produce pharmaceuticals, Putin said.
Pharmstandard, the country’s largest, accounted for 4.8 percent of retail drug sales in the first half, according to Pharmexpert. Germany’s Bayer had 3.8 percent of sales, followed by Italy’s Menarini Group and Paris-based Sanofi-Aventis, with 3.6 percent each.
The government spends $7.8 billion per year on drug purchases, Putin said.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.